Literature DB >> 24903624

Association between macroorchidism and intelligence in FMR1 premutation carriers.

Reymundo Lozano1, Scott Summers, Cristina Lozano, Yi Mu, David Hessl, Danh Nguyen, Flora Tassone, Randi Hagerman.   

Abstract

Characteristics of fragile X syndrome include macroorchidism and intellectual disability, which are associated with decreased FMRP levels. FMRP is highly expressed in many tissues, but primarily in the brain and testis. The relationship between these two characteristics has not previously been studied in the premutation or carrier state. To examine this among premutation carriers and a possible association with IQ, we evaluated macroorchidism status among 213 males including 142 premutation carriers and 71 controls. The prevalence of macroorchidism among premutation carriers was 32.4% (46 out of 142), and 5.6% among controls (4 out of 71, P < 0.0001). Among premutation carriers, the age-adjusted odds ratio (OR) of macroorchidism was significantly increased with increasing FMR1 mRNA (OR 1.84, 95% confidence interval [CI] 1.04-3.25; P = 0.035). With respect to the association between macroorchidism and IQ, after adjustment for number of CGG repeats and age, premutation carriers with macroorchidism had lower verbal IQ (104.67 ± 15.86, P = 0.0152) and full scale IQ (102.98 ± 15.78, P = 0.0227) than premutation carriers without macroorchidism (verbal IQ 112.38 ± 14.14, full scale IQ 110.24 ± 14.21). Similar associations were observed for both verbal IQ (P = 0.034) and full scale IQ (P = 0.039) after being adjusted for age and FMR1 mRNA. These preliminary data support a correlation between macroorchidism and lower verbal and full scale IQ in a relevant proportion of premutation carrier males. Whether this is due to higher levels of FMR1 mRNA or to lower FMRP levels it remains to be established.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  FMR1 gene; macroorchidism and biomarker; premutation

Mesh:

Substances:

Year:  2014        PMID: 24903624      PMCID: PMC4332881          DOI: 10.1002/ajmg.a.36624

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  43 in total

Review 1.  FMR1 and the continuum of primary ovarian insufficiency.

Authors:  Shannon D Sullivan; Corrine Welt; Stephanie Sherman
Journal:  Semin Reprod Med       Date:  2011-10-03       Impact factor: 1.303

2.  Cognitive-behavioral profiles of females with the fragile X mutation.

Authors:  Gene S Fisch
Journal:  Am J Med Genet A       Date:  2006-04-01       Impact factor: 2.802

Review 3.  Orthopaedic aspects of fragile-X syndrome.

Authors:  J R Davids; R J Hagerman; R E Eilert
Journal:  J Bone Joint Surg Am       Date:  1990-07       Impact factor: 5.284

4.  Testicular and pituitary inclusion formation in fragile X associated tremor/ataxia syndrome.

Authors:  Claudia M Greco; Kultida Soontrapornchai; Juthamas Wirojanan; John E Gould; Paul J Hagerman; Randi J Hagerman
Journal:  J Urol       Date:  2007-04       Impact factor: 7.450

5.  No widespread psychological effect of the fragile X premutation in childhood: evidence from a preliminary controlled study.

Authors:  G F Myers; M M Mazzocco; A Maddalena; A L Reiss
Journal:  J Dev Behav Pediatr       Date:  2001-12       Impact factor: 2.225

6.  The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy.

Authors:  Caroline J Moore; Eileen M Daly; Flora Tassone; Carolyn Tysoe; Nicole Schmitz; Virginia Ng; Xavier Chitnis; Philip McGuire; John Suckling; Kay E Davies; Randi J Hagerman; Paul J Hagerman; Kieran C Murphy; Declan G M Murphy
Journal:  Brain       Date:  2004-10-13       Impact factor: 13.501

7.  Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ataxia syndrome.

Authors:  Jim Grigsby; Angela G Brega; Karen Engle; Maureen A Leehey; Randi J Hagerman; Flora Tassone; David Hessl; Paul J Hagerman; Jennifer B Cogswell; Rachael E Bennett; Kylee Cook; Deborah A Hall; Lanee S Bounds; Marsha J Paulich; Ann Reynolds
Journal:  Neuropsychology       Date:  2008-01       Impact factor: 3.295

Review 8.  The FMR1 gene and fragile X-associated tremor/ataxia syndrome.

Authors:  J R Brouwer; R Willemsen; B A Oostra
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-09-05       Impact factor: 3.568

9.  Lifespan changes in working memory in fragile X premutation males.

Authors:  Kim M Cornish; Cary S Kogan; Lexin Li; Jeremy Turk; Sebastien Jacquemont; Randi J Hagerman
Journal:  Brain Cogn       Date:  2008-12-27       Impact factor: 2.310

10.  FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States.

Authors:  Flora Tassone; Ka Pou Iong; Tzu-Han Tong; Joyce Lo; Louise W Gane; Elizabeth Berry-Kravis; Danh Nguyen; Lisa Y Mu; Jennifer Laffin; Don B Bailey; Randi J Hagerman
Journal:  Genome Med       Date:  2012-12-21       Impact factor: 11.117

View more
  4 in total

Review 1.  Implications of the FMR1 Premutation for Children, Adolescents, Adults, and Their Families.

Authors:  Anne Wheeler; Melissa Raspa; Randi Hagerman; Marsha Mailick; Catharine Riley
Journal:  Pediatrics       Date:  2017-06       Impact factor: 7.124

2.  Psychosis and catatonia in fragile X: Case report and literature review.

Authors:  Tri Indah Winarni; Andrea Schneider; Neera Ghaziuddin; Andreea Seritan; Randi J Hagerman
Journal:  Intractable Rare Dis Res       Date:  2015-08

3.  Genetic mechanisms underlying spermatic and testicular traits within and among cattle breeds: systematic review and prioritization of GWAS results.

Authors:  Pablo Augusto de Souza Fonseca; Fernanda Caroline Dos Santos; Stephanie Lam; Aroa Suárez-Vega; Filippo Miglior; Flavio S Schenkel; Luiza de Almeida Ferreira Diniz; Samir Id-Lahoucine; Maria Raquel Santos Carvalho; Angela Cánovas
Journal:  J Anim Sci       Date:  2018-12-03       Impact factor: 3.159

4.  The FMRP-MOV10 complex: a translational regulatory switch modulated by G-Quadruplexes.

Authors:  Phillip J Kenny; Miri Kim; Geena Skariah; Joshua Nielsen; Monica C Lannom; Stephanie Ceman
Journal:  Nucleic Acids Res       Date:  2020-01-24       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.